LLY

1,074.05

-2.81%↓

JNJ

204.84

-1.39%↓

ABBV

226.66

-0.39%↓

UNH

331.47

+0.54%↑

AZN

92.61

-0.81%↓

LLY

1,074.05

-2.81%↓

JNJ

204.84

-1.39%↓

ABBV

226.66

-0.39%↓

UNH

331.47

+0.54%↑

AZN

92.61

-0.81%↓

LLY

1,074.05

-2.81%↓

JNJ

204.84

-1.39%↓

ABBV

226.66

-0.39%↓

UNH

331.47

+0.54%↑

AZN

92.61

-0.81%↓

LLY

1,074.05

-2.81%↓

JNJ

204.84

-1.39%↓

ABBV

226.66

-0.39%↓

UNH

331.47

+0.54%↑

AZN

92.61

-0.81%↓

LLY

1,074.05

-2.81%↓

JNJ

204.84

-1.39%↓

ABBV

226.66

-0.39%↓

UNH

331.47

+0.54%↑

AZN

92.61

-0.81%↓

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Open

3.74 -4.35

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.71

Max

3.88

Schlüsselkennzahlen
By Trading Economics
Einkommen	-3.3M -13M
Verkäufe	-1.4M 17M
EPS	-0.712
Gewinnspanne	-77.289
Angestellte	260
EBITDA	4M -8.1M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+123.47% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-6.7M 114M
Vorheriger Eröffnungskurs	8.09
Vorheriger Schlusskurs	3.74

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Nov. 2025, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27. Nov. 2025, 15:32 UTC

Akquisitionen, Fusionen, Übernahmen

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27. Nov. 2025, 23:50 UTC

Market Talk

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27. Nov. 2025, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. Nov. 2025, 16:05 UTC

Market Talk

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27. Nov. 2025, 16:04 UTC

Market Talk

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27. Nov. 2025, 15:54 UTC

Akquisitionen, Fusionen, Übernahmen

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27. Nov. 2025, 15:44 UTC

Akquisitionen, Fusionen, Übernahmen

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27. Nov. 2025, 15:43 UTC

Akquisitionen, Fusionen, Übernahmen

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27. Nov. 2025, 15:42 UTC

Akquisitionen, Fusionen, Übernahmen

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27. Nov. 2025, 15:41 UTC

Akquisitionen, Fusionen, Übernahmen

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27. Nov. 2025, 15:11 UTC

Market Talk

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27. Nov. 2025, 14:26 UTC

Market Talk

Hermes' Outperformance Gap Could Narrow -- Market Talk

27. Nov. 2025, 14:11 UTC

Market Talk

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27. Nov. 2025, 14:11 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

27. Nov. 2025, 13:35 UTC

Market Talk

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27. Nov. 2025, 13:33 UTC

Market Talk

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27. Nov. 2025, 13:22 UTC

Market Talk

Global Equities Roundup: Market Talk

27. Nov. 2025, 13:22 UTC

Market Talk

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27. Nov. 2025, 13:17 UTC

Market Talk

LVMH Should Be Able to Recover Next Year -- Market Talk

27. Nov. 2025, 11:13 UTC

Market Talk

European Gas Prices Come Under Pressure -- Market Talk

27. Nov. 2025, 11:07 UTC

Ergebnisse

Genting: Positive About Prospects Over Longer Term

27. Nov. 2025, 11:06 UTC

Ergebnisse

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27. Nov. 2025, 11:04 UTC

Ergebnisse

Genting: International Travel Demand Expected to Remain Resilient

27. Nov. 2025, 11:04 UTC

Ergebnisse

Genting: Global Growth Expected to Remain Subdued

27. Nov. 2025, 11:04 UTC

Ergebnisse

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27. Nov. 2025, 10:59 UTC

Ergebnisse

Genting Bhd 3Q Net Profit Fell 86% on Year

27. Nov. 2025, 10:58 UTC

Ergebnisse

Genting Bhd 3Q Rev Rose 14% on Year

27. Nov. 2025, 10:56 UTC

Ergebnisse

Genting Bhd 3Q Net MYR30.3M

27. Nov. 2025, 10:56 UTC

Ergebnisse

Genting Bhd 3Q EPS MYR0.0079

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

123.47% Vorteil

12-Monats-Prognose

Durchschnitt 8.38 USD 123.47%

Hoch 14 USD

Tief 3 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

5 ratings

Buy

Halten

Sell

Basierend auf 5 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.